Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Subscribe To Our Newsletter & Stay Updated
